Literature DB >> 12164726

A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter.

Zoran Brkanac1, Laura Bylenok, Magali Fernandez, Mark Matsushita, Hillary Lipe, John Wolff, David Nochlin, Wendy H Raskind, Thomas D Bird.   

Abstract

BACKGROUND: The autosomal dominant spinocerebellar ataxias (SCAs) are a clinically and genetically heterogeneous group of neurodegenerative disorders. Although molecular genetic studies have so far implicated 16 loci in the etiology of these diseases, approximately 30% of families with SCAs remain unlinked.
OBJECTIVES: To report the location of a gene causing a "pure" autosomal dominant cerebellar ataxia in one family and to describe the clinical phenotype. PATIENTS: We have identified a 4-generation American family of English and Dutch ethnicity with a pure cerebellar ataxia displaying an autosomal dominant pattern of inheritance. The disease typically has its onset in the third and fourth decades of life, shows no evidence of anticipation, progresses slowly, and does not appear to decrease life expectancy. Clinical DNA testing excluded SCA1, 2, 3, 6, 7, and 8.
METHODS: A genome-wide linkage analysis at a 10 centimorgan (cM) level was performed with samples from 26 family members (11 affected, 10 clinically unaffected at risk, and 5 spouses).
RESULTS: Assuming 90% penetrance, we found suggestive evidence of linkage to chromosome 19, with a lod score of 2.49 for D19S571. More detailed mapping in this region provided a maximum 2-point lod score of 2.57 at theta = 0 for D19S254 and a maximum multipoint lod score of 4.72 at D19S926. By haplotype construction a 22-cM critical region from D19S601 to the q telomere was defined.
CONCLUSIONS: We have mapped a gene for an autosomal dominant SCA to chromosome 19q13.4-qter in one family. The critical region overlaps with the locus for SCA14, a disease described in a single Japanese family and characterized by axial myoclonus. Myoclonus was not seen in the family we studied, but it remains possible that the 2 disorders are allelic variants.

Entities:  

Mesh:

Year:  2002        PMID: 12164726     DOI: 10.1001/archneur.59.8.1291

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.

Authors:  Sarah Doss; Jan Leo Rinnenthal; Tanja Schmitz-Hübsch; Alexander U Brandt; Sebastian Papazoglou; Silke Lux; Stephan Maul; Jens Würfel; Matthias Endres; Thomas Klockgether; Martina Minnerop; Friedemann Paul
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  Writer's Cramp as the First Symptom of Spinocerebellar Ataxia 14.

Authors:  Roberto Erro; Carla Cordivari; Mark J Edwards; Thomas Foltynie
Journal:  Mov Disord Clin Pract       Date:  2014-12-06

Review 3.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

4.  A novel H101Q mutation causes PKCgamma loss in spinocerebellar ataxia type 14.

Authors:  Isabel Alonso; Cristina Costa; André Gomes; Anabela Ferro; Ana I Seixas; Sérgio Silva; Vitor Tedim Cruz; Paula Coutinho; Jorge Sequeiros; Isabel Silveira
Journal:  J Hum Genet       Date:  2005-09-28       Impact factor: 3.172

5.  Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.

Authors:  Ravi Chopra; Aaron H Wasserman; Stefan M Pulst; Chris I De Zeeuw; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

Review 6.  The pathogenesis of spinocerebellar ataxia.

Authors:  Arnulf H Koeppen
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

7.  Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Authors:  Dong-Hui Chen; Zoran Brkanac; Christophe L M J Verlinde; Xiao-Jian Tan; Laura Bylenok; David Nochlin; Mark Matsushita; Hillary Lipe; John Wolff; Magali Fernandez; P J Cimino; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2003-03-17       Impact factor: 11.025

8.  Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14.

Authors:  Christos Ganos; Simone Zittel; Martina Minnerop; Odette Schunke; Christina Heinbokel; Christian Gerloff; Christine Zühlke; Peter Bauer; Thomas Klockgether; Alexander Münchau; Tobias Bäumer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 9.  The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review.

Authors:  Hélio A G Teive; Alex T Meira; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Mov Disord Clin Pract       Date:  2019-08-16

10.  Genetic and molecular aspects of spinocerebellar ataxias.

Authors:  Viktor Honti; László Vécsei
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.